The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Announces Research Agenda for 2016–2020

The ACR Announces Research Agenda for 2016–2020

March 9, 2016 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The definition of new therapeutic targets, improving the understanding of existing therapies, as well as the pathogenesis and genetic basis of rheumatic diseases, better engaging patients in their care—these are just a few of the concerns in the rheumatology community uncovered by the recent work of the ACR’s Committee on Research.

You Might Also Like
  • The ACR, ARHP Develop National Research Agenda for 2016–2020
  • ACR Publishes National Research Agenda for 2016–2020
  • The ACR Announces Advocacy Priorities for 2016
Also By This Author
  • The ACR’s Current Healthcare Policy Priorities

Since 2005, the Committee has been responsible for advancing the College’s research goals and providing leadership in research and research training in rheumatology via the ACR’s Research Agenda. The Agenda is designed to address critical areas of research in rheumatic diseases, including the need for new technology, new therapies and increased funding. Every five years, the Committee is charged with reassessing the National Research Agenda.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In developing the research priority areas for 2016–2020, the Committee solicited feedback from the membership of the ACR and the ARHP, which included investigators, academic clinicians, community rheumatologists and health professionals. This feedback from the rheumatology community helped identify important and unanswered questions faced by rheumatology patients and practitioners, which in turn, helped inform the 2016–2020 ACR Research Agenda.

Methodology
The development of the Research Agenda was a multilateral process that consisted of the following steps:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  1. A survey of the ACR and AHRP membership to identify important research questions;
  2. The Delphi exercise for question prioritization;
  3. The incorporation of stakeholder comments; and
  4. The refinement of the research agenda by the Committee on Research.

The Research Agenda can serve as a blueprint for the ACR’s strategic research goals and a means to stimulate additional partnerships. The ACR will continue to engage patients and practitioners to identify innovative approaches to improve quality of life and patient outcomes.

The general themes that emerged include:

  • The definition of new therapeutic targets and therapies, including regenerative medicine;
  • The improvement in our understanding of existing therapies, including predictors of response or adverse events, and the role of non-pharmacologic therapy;
  • A better understanding of the etiology, pathogenesis and genetic basis of rheumatic diseases, pain and fatigue, co-morbidities and the influence of aging;
  • Improved outcome measures, including patient-reported outcome measures and imaging modalities;
  • The role of the changing healthcare landscape in the U.S. for patients, rheumatologists and rheumatology health professionals; and
  • Optimizing the engagement of patients in their care.

The ACR is committed to advancing the research of rheumatic diseases. By continuing to push forward a comprehensive research agenda created with input from the rheumatology community and other interested stakeholders, the ACR will continue to have a direct and positive effect on the lives of patients with rheumatic diseases and on rheumatology research.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

To access the American College of Rheumatology’s 2016–2020 National Research Agenda, visit the ACR website. For additional information regarding the Agenda, contact ACR Research Senior Specialist Ngozi Afulezi.

Pages: 1 2 | Multi-Page

Filed Under: From the College Tagged With: American College of Rheumatology, Research, rheumatology

You Might Also Like:
  • The ACR, ARHP Develop National Research Agenda for 2016–2020
  • ACR Publishes National Research Agenda for 2016–2020
  • The ACR Announces Advocacy Priorities for 2016
  • ACR/ARHP 2016 Research Conferences Foster Exchanges with Colleagues Before Annual Meeting Start

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)